Update on Nationwide Fungal Meningitis and Other Infections Outbreak
In response to a nationwide outbreak of meningitis and stroke associated with a widely distributed medication, the Bureau for Public Health's Division of Infectious Disease Epidemiology (DIDE) has developed this informational webpage to provide updated guidance to clinicians and patients about contaminated medicination products received from the New England Compounding Center located in Framingham, Massachusetts. Patients suffered a variety of symptoms, including those associated with a rare form of fungal meningitis (brain infection) and stroke.
The CDC is working closely with the FDA and state partners to investigate an outbreak of meningitis among patients who had received an epidural steroid injection. The FDA has identified fungal contamination in recalled vials of steroid manufactured by the New England Compounding Center. The CDC and state health departments have released the names of approximately 75 healthcare facilities in 23 states that have received the contaminated product. One West Virginia facility, the Pars Interventional Pain and Wellness Center, in Parkersburg, Wood County, received the product.
- The CDC is leading the outbreak investigation.
- Approximately 223 patients were known to have received injections at the Pars Interventional Pain and Wellness Center, in Parkersburg, WV.
- DIDE assisted the clinic to notify all exposed patients.
- DIDE is working with health care providers to identify persons with signs of infection and to assure referral to health care.
DIDE will be updating the following chart to track cases associated with the outbreak. Only confirmed and probable cases using the CDC case definition are shown below:
||Infection At or Near the Site of Injection*
||Meningitis + Infection At or Near the Site of Injection*
|September 20, 2013
*Infections at or near the site of injection include paraspinal/spinal infections such as epidural abscess, phlegmon, discitis, vertebral osteomyelitis, or arachnoiditis